welcome to oneEDSvoice
- a positively charged Ehlers Danlos Syndrome community.- join today!
- login
scientific articles
The Successful Use of Recombinant Factor VIIa in a Patient with Vascular-Type Ehlers-Danlos Syndrome
source: Acta Anaesthesiologica Scandinavica
year: 2007
authors: Faber P, Craig WL, Duncan JL, Holliday K
summary/abstract:Vascular-type Ehlers-Danlos syndrome is an inherited connective tissue disorder resulting in an increased risk of serious peri-operative bleeding during surgery for spontaneous organ or vessel rupture. The excessive bleeding may result in coagulopathy, and thus compound the difficulty in securing surgical haemostasis. With the advent of recombinant factor VIIa, a new therapy has become available for the management of intractable surgical bleeding.
organization: Aberdeen Royal InfirmaryDOI: 10.1111/j.1399-6576.2007.01416.x
read more full text source
expertly curated content related to this topic
-
Familial Cervical Artery Dissections: Clinical, Morphologic, and Genetic StudiesBACKGROUND AND PURPOSE: Genetic risk fa...
-
Ehlers-Danlos syndrome (Satumaan)Zebra is the mascot for Ehlers Danlos sy...
-
Cardiac Valve Disease: An Unreported Feature in Ehlers Danlos Syndrome Arthrocalasia Type?Ehlers Danlos syndrome (EDS) athrocalasi...
-
Frank Gargano PT, DPT, OCS, CIDN, MCTA, CWTFrank Gargano graduated from Ohio Univer...
-
Dr Tim JenkinsonDr Tim Jenkinson has been a consultant i...
-
Brave 26 year old, Sara Geurts, is launching modeling career while having Dermatosparaxis Ehlers-Danlos syndromeA woman in her twenties with a rare skin...
-
Cynthia Allen, GCFP, STMICynthia Allen is a movement specialist t...
